About this trial
Cardiotocography (CTG) is a cornerstone of intrapartum fetal monitoring but requires a minimum of 30 minutes for a reliable trace, creating a significant bottleneck in high-volume, low-resource settings like Egypt As it is time-consuming and resource intensive. This leads to delays in care and increased workload for healthcare providers. A shortened, yet accurate, CTG protocol could drastically improve workflow and resource allocation without compromising fetal safety.
Eligibility criteria
Qualifiers
Singleton pregnancy.
Gestational age ≥ 37 weeks.
Vertex presentation.
Active first stage of labor (cervical dilation ≥ 4 cm).
Disqualifiers
• Multiple gestation.
Known major fetal anomaly.
Non-vertex presentation.
Indication for continuous CTG (e.g., meconium-stained liquor, antepartum hemorrhage).
Trial design
Treatments tested in this trial
- Not listed